Interleukin-2-inducible T-cell kinase inhibitors modify functional polarization of human peripheral T-cell lymphoma cells.
Mamand, Sami
Interleukin-2-inducible T-cell kinase inhibitors modify functional polarization of human peripheral T-cell lymphoma cells. [electronic resource] - Blood advances 03 2019 - 705-710 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2473-9537
10.1182/bloodadvances.2018027821 doi
Adult
Aged
CD4-Positive T-Lymphocytes--physiology
Cell Differentiation--drug effects
Cell Line
Cell Polarity--drug effects
Female
Humans
Lymphoma, T-Cell, Peripheral--pathology
Protein Kinase Inhibitors--pharmacology
Protein-Tyrosine Kinases--antagonists & inhibitors
T-Lymphocytes, Regulatory
Interleukin-2-inducible T-cell kinase inhibitors modify functional polarization of human peripheral T-cell lymphoma cells. [electronic resource] - Blood advances 03 2019 - 705-710 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2473-9537
10.1182/bloodadvances.2018027821 doi
Adult
Aged
CD4-Positive T-Lymphocytes--physiology
Cell Differentiation--drug effects
Cell Line
Cell Polarity--drug effects
Female
Humans
Lymphoma, T-Cell, Peripheral--pathology
Protein Kinase Inhibitors--pharmacology
Protein-Tyrosine Kinases--antagonists & inhibitors
T-Lymphocytes, Regulatory